Pietro Napodano

1.1k total citations
21 papers, 400 citations indexed

About

Pietro Napodano is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Pietro Napodano has authored 21 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Rheumatology. Recurrent topics in Pietro Napodano's work include Renal Diseases and Glomerulopathies (15 papers), Vasculitis and related conditions (10 papers) and Systemic Lupus Erythematosus Research (5 papers). Pietro Napodano is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Vasculitis and related conditions (10 papers) and Systemic Lupus Erythematosus Research (5 papers). Pietro Napodano collaborates with scholars based in Italy and United States. Pietro Napodano's co-authors include Giuseppe D’Amico, Renato Alberto Sinico, Franco Ferrario, Claudio Bazzi, Maria Pia Rastaldi, Girolamo Arrigo, Patrizia Scaini, Antonella Radice, G Ortisi and Giampaola Pesce and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and BioMed Research International.

In The Last Decade

Pietro Napodano

20 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pietro Napodano Italy 10 307 150 85 83 62 21 400
Angelo Testa France 9 330 1.1× 116 0.8× 77 0.9× 39 0.5× 75 1.2× 14 470
Anirban Ganguli India 9 273 0.9× 145 1.0× 107 1.3× 35 0.4× 49 0.8× 17 433
Y-L. Chan Taiwan 8 305 1.0× 103 0.7× 94 1.1× 87 1.0× 60 1.0× 12 447
Emilio Rivolta Italy 7 299 1.0× 75 0.5× 106 1.2× 99 1.2× 67 1.1× 10 425
Keita Hirano Japan 12 294 1.0× 113 0.8× 74 0.9× 33 0.4× 55 0.9× 46 437
Hee Yeon Cho South Korea 11 184 0.6× 67 0.4× 54 0.6× 64 0.8× 69 1.1× 13 328
Sean Barbour Canada 11 326 1.1× 89 0.6× 97 1.1× 43 0.5× 72 1.2× 41 456
Misao Tsukada Japan 11 318 1.0× 80 0.5× 65 0.8× 51 0.6× 29 0.5× 31 390
Yoshitaka Koshino Japan 8 229 0.7× 53 0.4× 48 0.6× 52 0.6× 39 0.6× 28 333
Leslie Powell United States 6 456 1.5× 89 0.6× 146 1.7× 47 0.6× 101 1.6× 8 522

Countries citing papers authored by Pietro Napodano

Since Specialization
Citations

This map shows the geographic impact of Pietro Napodano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pietro Napodano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pietro Napodano more than expected).

Fields of papers citing papers by Pietro Napodano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pietro Napodano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pietro Napodano. The network helps show where Pietro Napodano may publish in the future.

Co-authorship network of co-authors of Pietro Napodano

This figure shows the co-authorship network connecting the top 25 collaborators of Pietro Napodano. A scholar is included among the top collaborators of Pietro Napodano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pietro Napodano. Pietro Napodano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cassia, Matthias, et al.. (2021). COVID-19 Infection and Acute Kidney Injury: Cause or Complication?. Blood Purification. 51(3). 288–291. 1 indexed citations
2.
Bazzi, Claudio, Teresa Maria Seccia, Pietro Napodano, et al.. (2020). High Blood Pressure Is Associated with Tubulointerstitial Damage along with Glomerular Damage in Glomerulonephritis. A large Cohort Study. Journal of Clinical Medicine. 9(6). 1656–1656. 6 indexed citations
3.
Radice, Antonella, Federico Pieruzzi, Barbara Trezzi, et al.. (2017). Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Journal of Nephrology. 31(2). 271–278. 55 indexed citations
4.
Ferrario, Franco, Pietro Napodano, Antonio Giordano, et al.. (2015). Peculiar Type of Focal and Segmental Lupus Glomerulitis: Glomerulonephritis or Vasculitis?. Contributions to nephrology. 99. 86–93. 3 indexed citations
5.
Ferrario, Franco, Pietro Napodano, Maria Pia Rastaldi, & Giuseppe D’Amico. (2015). Capillaritis in IgA Nephropathy. Contributions to nephrology. 111. 8–12. 2 indexed citations
6.
Sinico, Renato Alberto, Gina Gregorini, Antonella Radice, et al.. (2015). Clinical Significance of Autoantibodies to Myeloperoxidase in Vasculitic Syndromes. Contributions to nephrology. 94. 31–37.
7.
Radice, Antonella, Barbara Trezzi, Umberto Maggiore, et al.. (2015). Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Autoimmunity Reviews. 15(2). 146–154. 75 indexed citations
8.
9.
Bazzi, Claudio, et al.. (2012). Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy. Journal of Nephrology. 25(5). 810–818. 7 indexed citations
10.
Sinico, Renato Alberto, Ilaria Cavazzana, Monica Nuzzo, et al.. (2010). Renal Involvement in Primary Antiphospholipid Syndrome. Clinical Journal of the American Society of Nephrology. 5(7). 1211–1217. 58 indexed citations
11.
Bazzi, Claudio, et al.. (2009). Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.. PubMed. 22(3). 387–96. 7 indexed citations
12.
Bazzi, Claudio, et al.. (2009). In Crescentic IgA Nephropathy, Fractional Excretion of IgG in Combination with Nephron Loss Is the Best Predictor of Progression and Responsiveness to Immunosuppression. Clinical Journal of the American Society of Nephrology. 4(5). 929–935. 18 indexed citations
13.
Fornasieri, Alessandro, et al.. (2003). Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.. PubMed. 15(4). 349–57. 11 indexed citations
14.
Bazzi, Claudio, Concetta Petrini, Virginia Rizza, et al.. (2003). Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: A pilot study. American Journal of Kidney Diseases. 41(2). 328–335. 21 indexed citations
15.
D’Amico, Giuseppe, Pietro Napodano, Franco Ferrario, Maria Pia Rastaldi, & Girolamo Arrigo. (2001). Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall. Kidney International. 59(2). 682–692. 32 indexed citations
16.
Ferrario, Franco, et al.. (1994). Critical re-evaluation of 41 cases of "idiopathic" crescentic glomerulonephritis.. PubMed. 41(1). 1–9. 24 indexed citations
17.
Ferrario, Franco, Pietro Napodano, Antonio Giordano, et al.. (1993). Rapidly Progressive Glomerulonephritis (RPGN): Is there Still an “Idiopathic” Subgroup?. Advances in experimental medicine and biology. 336. 431–434. 1 indexed citations
18.
Ferrario, Francesca, et al.. (1992). [Morphological basis of the classification of crescent glomerulonephritis].. PubMed. 13(6). 263–5. 1 indexed citations
19.
Canton, Antonio Dal, Pietro Napodano, Giorgio Fuíano, et al.. (1989). Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney International. 36(6). 1086–1092. 56 indexed citations
20.
Conte, Giuseppe, Massimo Sabbatini, Pietro Napodano, et al.. (1988). Dopamine counteracts the acute renal effects of cyclosporine in normal subjects.. PubMed. 20(3 Suppl 3). 563–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angelo Testa Breakdown of academic impact, for papers by Anirban Ganguli Breakdown of academic impact, for papers by Y-L. Chan Breakdown of academic impact, for papers by Emilio Rivolta Breakdown of academic impact, for papers by Keita Hirano Breakdown of academic impact, for papers by Hee Yeon Cho Breakdown of academic impact, for papers by Sean Barbour Breakdown of academic impact, for papers by Misao Tsukada Breakdown of academic impact, for papers by Yoshitaka Koshino Breakdown of academic impact, for papers by Leslie Powell
Rankless by CCL
2026